JP2019517549A5 - - Google Patents

Info

Publication number

JP2019517549A5

JP2019517549A5 JP2018564296A JP2018564296A JP2019517549A5 JP 2019517549 A5 JP2019517549 A5 JP 2019517549A5 JP 2018564296 A JP2018564296 A JP 2018564296A JP 2018564296 A JP2018564296 A JP 2018564296A JP 2019517549 A5 JP2019517549 A5 JP 2019517549A5

Authority

JP

Japan

Prior art keywords

seq

amino acid

acid sequence

chain variable

variable domain

Prior art date

2017-06-08

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Pending

Links

• Espacenet
• Global Dossier
• Discuss

• 125000003275 alpha amino acid group Chemical group 0.000 claims description 108
• 239000003112 inhibitor Substances 0.000 claims description 44
• 108010029869 Proto-Oncogene Proteins c-raf Proteins 0.000 claims description 42
• 102100033479 RAF proto-oncogene serine/threonine-protein kinase Human genes 0.000 claims description 42
• 208000002154 non-small cell lung carcinoma Diseases 0.000 claims description 26
• 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 claims description 26
• 238000011282 treatment Methods 0.000 claims description 25
• 102100030708 GTPase KRas Human genes 0.000 claims description 24
• 101000984753 Homo sapiens Serine/threonine-protein kinase B-raf Proteins 0.000 claims description 24
• 102100027103 Serine/threonine-protein kinase B-raf Human genes 0.000 claims description 24
• 201000001441 melanoma Diseases 0.000 claims description 22
• 239000008194 pharmaceutical composition Substances 0.000 claims description 20
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 19
• 230000002062 proliferating effect Effects 0.000 claims description 19
• 206010033128 Ovarian cancer Diseases 0.000 claims description 16
• 206010061535 Ovarian neoplasm Diseases 0.000 claims description 16
• 102100039788 GTPase NRas Human genes 0.000 claims description 14
• 101000744505 Homo sapiens GTPase NRas Proteins 0.000 claims description 14
• 102000043136 MAP kinase family Human genes 0.000 claims description 12
• 108091054455 MAP kinase family Proteins 0.000 claims description 12
• 201000010099 disease Diseases 0.000 claims description 11
• 230000005723 MEK inhibition Effects 0.000 claims description 10
• 229940125374 mitogen-activated extracellular signal-regulated kinase inhibitor Drugs 0.000 claims description 10
• 150000003839 salts Chemical class 0.000 claims description 10
• 238000002648 combination therapy Methods 0.000 claims description 9
• 229940122633 C-raf kinase inhibitor Drugs 0.000 claims description 8
• 206010028980 Neoplasm Diseases 0.000 claims description 8
• 208000035475 disorder Diseases 0.000 claims description 8
• 229940126062 Compound A Drugs 0.000 claims description 6
• NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 claims description 6
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 4
• 101100519207 Mus musculus Pdcd1 gene Proteins 0.000 claims description 4
• 208000037844 advanced solid tumor Diseases 0.000 claims description 4
• 239000003937 drug carrier Substances 0.000 claims description 4
• 230000004075 alteration Effects 0.000 claims description 3
• 239000004480 active ingredient Substances 0.000 claims description 2
• 201000011510 cancer Diseases 0.000 claims description 2
• 239000002552 dosage form Substances 0.000 claims description 2
• 239000003814 drug Substances 0.000 claims description 2
• 238000009169 immunotherapy Methods 0.000 claims description 2
• 238000002347 injection Methods 0.000 claims description 2
• 239000007924 injection Substances 0.000 claims description 2
• 239000006186 oral dosage form Substances 0.000 claims description 2
• 238000004806 packaging method and process Methods 0.000 claims description 2
• 239000000203 mixture Substances 0.000 claims 23
• 101000584612 Homo sapiens GTPase KRas Proteins 0.000 claims 11
• 230000035772 mutation Effects 0.000 claims 11
• 206010069755 K-ras gene mutation Diseases 0.000 claims 2
• 229940127555 combination product Drugs 0.000 claims 1
• 239000000890 drug combination Substances 0.000 claims 1
• 238000009472 formulation Methods 0.000 claims 1
• 238000002560 therapeutic procedure Methods 0.000 claims 1
• 238000000034 method Methods 0.000 description 16
• 238000011284 combination treatment Methods 0.000 description 1
• 229940079593 drug Drugs 0.000 description 1